IDH1 and central nervous system cancer: Characterization of the molecular landscape of lower-grade gliomas confirmed the presence of a known IDH1 mutation and 1p/19q codeletion (whole-arm loss of the long arm of chromosome 1 and the short arm of chromosome 19) and their role as a predictive markers [13,14].